The effect of intralipid in recurrent implantation failure

The effect of intravenous intralipid administration on reproductive outcomes for couples with recurrent implantation failure in non-donor in vitro fertilization /intracytoplasmic injection cycles

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20221016056198N2

Enrollment

Registered

2023-03-16

Start date

2023-02-04

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertile patient with recurrent implantation failure.

Interventions

Intervention 1: Intervention group : Patients with a history of repeated implantation failure receiving Intralipid in embryo freeze transfer cycles. Intervention 2: Control group : Patients with a his

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients with history of recurrent implantation failure who aged less than 40 years Patients with normal hormone profile Patients with BMI 20-32

Exclusion criteria

Exclusion criteria: Women with recurrent pregnancy loss Women with aged more than 40 years Women with endometriosis Women with coagulation disorder Women with allergy to soya and egg Women with Liver, Heart and Renal disease Women with high cholestrole

Design outcomes

Primary

Measure	Time frame
Implantation rate :The ratio of implanted embryos to transferred embryos. Timepoint: 7 weeks after embryo transfer. Method of measurement: Vaginal Sonography.	—

Secondary

Measure	Time frame
Biochemical pregnancy rate. Timepoint: 14 days after embryo transfer. Method of measurement: Blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazanin Hajizadeh

Shahid Beheshti University of Medical Sciences

Hajizadeh.nazanin94@yahoo.com+98 21 2243 2600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026